Annual Reports in Medicinal Chemistry Volume 66 provides timely and critical reviews of important topics in medicinal chemistry, with an emphasis on emerging topics in the biological sciences that are expected to provide the basis for entirely new future therapies. Focus in this new release is on The anti-inflammatory and immunological properties of GLP-1R and How to reduce side effects of GLP-1 based obesity medications.
Table of Contents
1: The anti-infiammatory and immunological properties of GLP-1R 2: GLP-1-based multipharmacology: biased signaling as a determinant of therapeutic efficacy 3: How to reduce side effects of GLP-1 based obesity medications
The sample excerpt is provided to help you make an informed purchasing decision. It is not intended to serve as free content or replace a full report. To ensure the sample aligns with your specific needs, our team will contact you to better understand your requirements.
An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net
This report can be tailored to focus on a specific country, region, continent, or provide global coverage. Please indicate your regions of interest and share any additional questions you may have. Our team strives to respond to all inquiries within the same business day.
An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net